Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rose-John

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Scandinavian Journal of Immunology|April 28, 2006
Interleukin-6 trans-signalling in chronic inflammation and cancerJ Scheller, N Ohnesorge, S Rose-John
Biochemical and Biophysical Research Communications|August 31, 1987
The induction of ornithine decarboxylase by the tumor promoter TPA is controlled at the post-transcriptional level in murine Swiss 3T3 fibroblastsS Rose-John, G Rincke, F Marks
The European Journal of Neuroscience|October 6, 1999
Neural activities of IL-6-type cytokines often depend on soluble cytokine receptorsP März, U Otten, S Rose-John
Gene|December 30, 1988
Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblastsS Rose-John, A Dietrich, F Marks
Biochemistry International|July 1, 1989
Expression of the kinase domain of mouse protein kinase C in E. coliA Dietrich, S Rose-John, F Marks
Blood|November 10, 1998
Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesisM Peters, A M Müller, S Rose-John
Plant Physiology|June 1, 1987
An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater riceA B Bleecker, S Rose-John, H Kende
Trends in Biotechnology|November 4, 2000
New perspectives on the design of cytokines and growth factorsK J Kallen, J Grötzinger, S Rose-John
Annals of the New York Academy of Sciences|July 21, 1995
The soluble interleukin-6 receptorS Rose-John, M Ehlers, J Grötzinger, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?K J Kallen, P R Galle, S Rose-John
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Scandinavian Journal of Immunology|April 28, 2006
Interleukin-6 trans-signalling in chronic inflammation and cancerJ Scheller, N Ohnesorge, S Rose-John
Biochemical and Biophysical Research Communications|August 31, 1987
The induction of ornithine decarboxylase by the tumor promoter TPA is controlled at the post-transcriptional level in murine Swiss 3T3 fibroblastsS Rose-John, G Rincke, F Marks
The European Journal of Neuroscience|October 6, 1999
Neural activities of IL-6-type cytokines often depend on soluble cytokine receptorsP März, U Otten, S Rose-John
Gene|December 30, 1988
Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblastsS Rose-John, A Dietrich, F Marks
Biochemistry International|July 1, 1989
Expression of the kinase domain of mouse protein kinase C in E. coliA Dietrich, S Rose-John, F Marks
Blood|November 10, 1998
Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesisM Peters, A M Müller, S Rose-John
Plant Physiology|June 1, 1987
An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater riceA B Bleecker, S Rose-John, H Kende
Trends in Biotechnology|November 4, 2000
New perspectives on the design of cytokines and growth factorsK J Kallen, J Grötzinger, S Rose-John
Annals of the New York Academy of Sciences|July 21, 1995
The soluble interleukin-6 receptorS Rose-John, M Ehlers, J Grötzinger, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?K J Kallen, P R Galle, S Rose-John
Pageof 17